# THN Global MCP Server

Pharma AI IP engine MCP server for drug discovery acceleration via patent landscape analysis and AI-driven drug development strategies.

## Overview

THN Global is a sophisticated MCP (Model Context Protocol) server designed for pharmaceutical and biotech companies. It leverages AI and data intelligence to accelerate drug discovery by providing comprehensive patent landscape analysis, IP strategy development, regulatory guidance, market intelligence, and collaboration matching.

**Market Context**: The AI drug discovery market is projected to grow from USD 2.35B (current) to USD 8.1B by 2030, representing 25% CAGR. THN Global positions biotech companies near the Waterloo ecosystem to capitalize on this growth.

## Features

### 1. Patent Landscape Analysis
- **Comprehensive Patent Mapping**: Analyze patent density across therapeutic areas and regions
- **Key Patent Holder Identification**: Identify major players and their focus areas
- **White Space Opportunities**: Discover unpatented or under-patented therapeutic opportunities
- **Freedom-to-Operate Assessment**: Evaluate blocking patents and design-around possibilities
- **Competitive Landscape**: Track major competitors and emerging players, identify technology trends

### 2. AI-Driven Drug Discovery Assessment
- **Pipeline Feasibility Scoring**: Evaluate development pipeline viability (0-100 score)
- **Competitive Program Analysis**: Identify competing programs and their development stages
- **Timeline Estimation**: Project development timelines based on therapeutic approach
- **Regulatory Pathway Determination**: Recommend FDA/EMA pathways
- **Risk Assessment**: Identify key technical, regulatory, and commercial risks
- **Cost Projections**: Estimate phase-by-phase and total development costs with risk adjustment

### 3. Intellectual Property Strategy
- **Strategic IP Recommendations**: Develop comprehensive IP protection strategies
- **Patent Filing Priorities**: Prioritize patent filings by jurisdiction and timing
- **Defensive Strategies**: Build IP thicketing and competitive moats
- **Licensing Opportunities**: Identify licensing and royalty opportunities
- **Cost and ROI Analysis**: Project IP investment costs and return timelines

### 4. Regulatory Pathway Mapping
- **FDA Pathway Determination**: Identify appropriate FDA pathways (505(b)(1), 505(b)(2), 351(a), 351(k))
- **EMA Pathway Selection**: Determine EMA centralized/decentralized review routes
- **Required Studies**: Outline Phase 1, 2, 3 study requirements
- **Timeline Estimation**: Project regulatory review timelines
- **Fee Schedules**: Provide current FDA/EMA filing fees
- **Accelerated Pathways**: Identify breakthrough, priority review, and accelerated approval eligibility

### 5. Pharma Market Intelligence
- **Market Sizing**: Current and projected market sizes by therapeutic area
- **Key Player Analysis**: Market share, key products, pipeline composition
- **Pricing Trends**: Launch prices, erosion rates, generic entry timelines
- **Reimbursement Landscape**: Payer trends and coverage requirements
- **Market Access Barriers**: Regulatory, financial, and commercial barriers
- **Growth Drivers**: Market dynamics and expansion opportunities

### 6. Collaboration and Partnership Matching
- **Partner Identification**: Match with licensing partners, co-development collaborators
- **Strategic Fit Assessment**: Score technology and strategic fit (0-100)
- **Deal Structure Recommendations**: Typical upfront payments, milestones, royalties
- **Comparable Transactions**: Reference similar deals and valuations
- **Success Probability**: Assess partnership success likelihood

## Installation

### Requirements
- Node.js ≥ 18.0.0
- npm or yarn

### Setup

```bash
# Clone or navigate to the server directory
cd mcp-servers/thn-global

# Install dependencies
npm install

# Build the TypeScript
npm run build

# Start the server
npm start
```

## Usage

### As an MCP Server

The server connects via stdio and exposes 6 tools:

```bash
npm start
```

### Tool Invocation Examples

#### 1. Patent Landscape Analysis

```json
{
  "tool": "thn_patent_landscape",
  "arguments": {
    "therapeutic_area": "oncology",
    "molecule_type": "small_molecule",
    "target_pathway": "PD-L1 checkpoint pathway",
    "date_range": {
      "start_year": 2015,
      "end_year": 2024
    }
  }
}
```

**Returns**:
- Patent density map by region
- Key patent holders (Pfizer, Roche, Merck, etc.)
- White space opportunities
- Freedom-to-operate assessment
- Competitive landscape (major competitors, emerging players, tech trends)

#### 2. Drug Discovery AI Assessment

```json
{
  "tool": "thn_drug_discovery_ai",
  "arguments": {
    "target_disease": "triple-negative breast cancer",
    "approach": "small_molecule",
    "development_stage": "preclinical",
    "budget_range": {
      "min_usd_millions": 50,
      "max_usd_millions": 150
    }
  }
}
```

**Returns**:
- Feasibility score (0-100)
- Competitive programs in space
- Estimated timeline (months)
- Regulatory pathway recommendation
- Key risks and risk mitigation
- Cost projections with risk adjustment
- Technical readiness score

#### 3. IP Strategy Development

```json
{
  "tool": "thn_ip_strategy",
  "arguments": {
    "innovation_type": "composition_of_matter",
    "jurisdiction": ["US", "EU", "JP"],
    "existing_patents": ["US10123456B2"],
    "competitive_landscape": "Moderate patent density, 3-4 competitors"
  }
}
```

**Returns**:
- IP strategy recommendations
- Patent filing priorities by jurisdiction
- Defensive strategies (patent thicketing, etc.)
- Licensing opportunities and revenue potential
- Estimated total costs
- ROI timeline (years)

#### 4. Regulatory Pathway Mapping

```json
{
  "tool": "thn_regulatory_pathway",
  "arguments": {
    "drug_type": "small_molecule",
    "therapeutic_area": "oncology",
    "target_market": ["US", "EU"],
    "development_phase": "phase_2"
  }
}
```

**Returns**:
- FDA pathway (e.g., 505(b)(1))
- EMA pathway (centralized/decentralized)
- Required studies (Phase 1, 2, 3 details)
- Total regulatory timeline (months)
- Key milestones with projected timelines
- Priority review eligibility
- Accelerated pathway availability
- Current fee schedules

#### 5. Market Intelligence

```json
{
  "tool": "thn_market_intelligence",
  "arguments": {
    "therapeutic_area": "immunology",
    "geography": ["North_America", "Europe"],
    "time_horizon": "5yr"
  }
}
```

**Returns**:
- Current and 5-year market size
- CAGR and growth projections
- Key players and market share
- Pipeline analysis by stage
- Pricing trends and erosion rates
- Reimbursement landscape
- Market access barriers
- Growth drivers

#### 6. Collaboration Matching

```json
{
  "tool": "thn_collaboration_match",
  "arguments": {
    "technology_area": "CAR-T cell therapy",
    "partnership_type": "co-development",
    "stage": "phase_2",
    "geographic_preference": ["North_America", "Europe"]
  }
}
```

**Returns**:
- Potential partners with fit scores
- Deal structure recommendations
- Comparable transactions
- Success probability
- Typical deal terms (upfront, milestones, royalties)

## Tool Reference

### thn_patent_landscape

**Purpose**: Comprehensive patent landscape analysis for therapeutic area

**Input Parameters**:
- `therapeutic_area` (string): Target therapeutic area (oncology, immunology, cardiovascular, etc.)
- `molecule_type` (enum): small_molecule | biologic | antibody | protein | rna | other
- `target_pathway` (string): Target biological pathway or mechanism
- `date_range.start_year` (number): Start year (1980-2100)
- `date_range.end_year` (number): End year (1980-2100)

**Output**:
- Patent density map with regional breakdown
- Top 5 patent holders with filing trends
- 5+ white space opportunities
- Freedom-to-operate risk assessment
- Major competitors and emerging players
- Current technology trends

---

### thn_drug_discovery_ai

**Purpose**: AI-assisted drug discovery pipeline assessment and feasibility analysis

**Input Parameters**:
- `target_disease` (string): Target disease indication
- `approach` (enum): small_molecule | biologics | gene_therapy | cell_therapy
- `development_stage` (enum): discovery | preclinical | phase_1 | phase_2 | phase_3 | nda_stage
- `budget_range.min_usd_millions` (number): Minimum budget
- `budget_range.max_usd_millions` (number): Maximum budget

**Output**:
- Feasibility score (0-100)
- Top competing programs
- Estimated development timeline
- Recommended regulatory pathway
- Key technical and commercial risks
- Phase-by-phase cost projections
- Risk-adjusted NPV
- Technical readiness score (0-100)

---

### thn_ip_strategy

**Purpose**: Develop comprehensive intellectual property strategy

**Input Parameters**:
- `innovation_type` (enum): composition_of_matter | method_of_use | device | formulation | manufacturing_process | combination_therapy
- `jurisdiction` (array): US | EU | JP | CN | AU | CA | IN | BR
- `existing_patents` (array, optional): List of existing patent numbers
- `competitive_landscape` (string, optional): Description of competitive IP landscape

**Output**:
- 6+ strategic IP recommendations
- Patent filing priorities by jurisdiction and type
- Defensive IP strategies
- Licensing opportunities by territory
- Estimated 5-year prosecution and maintenance costs
- Projected ROI timeline (years)

---

### thn_regulatory_pathway

**Purpose**: Map regulatory pathway for drug approval across markets

**Input Parameters**:
- `drug_type` (enum): small_molecule | biologic | device | combination
- `therapeutic_area` (enum): oncology | cardiovascular | immunology | neurology | infectious_disease | rare_disease | metabolic
- `target_market` (array): US | EU | JP | CN | CA | AU
- `development_phase` (enum): discovery | preclinical | phase_1 | phase_2 | phase_3 | nda_stage

**Output**:
- FDA pathway recommendation
- EMA pathway recommendation
- Required studies (Phase 1, 2, 3) with duration and patient counts
- Total regulatory timeline (months)
- Key regulatory milestones
- Current FDA/EMA filing fees
- Priority review eligibility
- Breakthrough/accelerated pathway availability

---

### thn_market_intelligence

**Purpose**: Pharma market intelligence and competitive analysis

**Input Parameters**:
- `therapeutic_area` (string): Target therapeutic area
- `geography` (array): North_America | Europe | Asia_Pacific | Global
- `time_horizon` (enum): 1yr | 3yr | 5yr | 10yr

**Output**:
- Current market size and 5-year projection
- CAGR and growth rate
- Top 3-5 key players with market share
- Pipeline analysis by development stage
- Pricing trends and generic entry timelines
- Reimbursement and payer landscape
- Market access barriers
- Key market drivers (demographic, clinical, economic)

---

### thn_collaboration_match

**Purpose**: Identify and match potential research and commercial collaborators

**Input Parameters**:
- `technology_area` (string): Technology focus area
- `partnership_type` (enum): licensing | co-development | acquisition | joint_venture | research_collaboration
- `stage` (enum): discovery | preclinical | phase_1 | phase_2 | phase_3 | commercial
- `geographic_preference` (array): North_America | Europe | Asia_Pacific | Global

**Output**:
- Top 3-5 potential partner organizations
- Technology and strategic fit scores (0-100)
- Financial capacity assessment
- Deal structure recommendations with ranges
- Comparable transactions and precedent deals
- Partnership success probability (%)

## Development

### Build

```bash
npm run build
```

### Development Mode (watch)

```bash
npm run watch
```

### Code Quality

```bash
# Lint
npm run lint

# Format
npm run format
```

## Architecture

### Directory Structure

```
thn-global/
├── src/
│   ├── index.ts          # Server entry point and request handlers
│   ├── types.ts          # TypeScript type definitions
│   ├── schemas.ts        # Zod validation schemas
│   └── tools.ts          # Tool implementations and helpers
├── dist/                 # Compiled JavaScript (generated)
├── package.json          # Dependencies and scripts
├── tsconfig.json         # TypeScript configuration
├── .gitignore            # Git ignore rules
└── README.md             # This file
```

### Key Dependencies

- **@modelcontextprotocol/sdk**: MCP protocol implementation
- **zod**: Runtime type validation and schema definition
- **TypeScript**: Static typing and compilation

## Performance Considerations

- **Caching**: All analyses are computed fresh for accuracy
- **Async Operations**: All tool operations are async-ready
- **Error Handling**: Comprehensive validation and error messaging
- **Resource Usage**: Designed for low resource consumption with instant responses

## Security and Privacy

- **No External APIs**: All data processing is internal
- **Input Validation**: Zod schemas validate all inputs
- **No Data Persistence**: No storage of user data or queries
- **Type Safety**: Full TypeScript for safety and reliability

## Data Sources and Methodology

Analysis is based on:
- Patent databases (USPTO, EPO, WIPO)
- FDA/EMA regulatory guidance
- Clinical trial databases (ClinicalTrials.gov)
- Pharma market intelligence platforms
- Deal databases and precedent transactions
- Published academic and industry research

*Note: This is a demonstration implementation with simulated but realistic data. In production, integrate with actual patent databases, regulatory databases, and market intelligence APIs.*

## Use Cases

### 1. Drug Development Companies
- Evaluate pipeline feasibility before major investments
- Develop IP strategy for competitive advantage
- Assess regulatory pathways for global launches
- Identify partnership opportunities

### 2. Investment and Venture Capital
- Conduct due diligence on biotech targets
- Assess market opportunity and competition
- Evaluate technical and regulatory risks
- Benchmark valuation against comparable transactions

### 3. Patent and IP Professionals
- Analyze patent landscapes and white space
- Develop filing strategies
- Evaluate freedom-to-operate
- Identify licensing opportunities

### 4. Business Development
- Identify collaboration partners
- Assess deal structures and precedents
- Evaluate market access strategies
- Track competitive intelligence

### 5. Regulatory Affairs
- Map regulatory pathways
- Identify expedited approval opportunities
- Plan clinical development programs
- Prepare regulatory submissions

## License

CC0-1.0 - Public Domain

## Author

THN Global — MEOK AI Health AI

**Website**: https://thn-global.com

**Location**: Waterloo Biotech Ecosystem, Canada

## Support and Contact

For questions, issues, or feature requests, please contact THN Global through the official website.

## Disclaimer

This MCP server provides analytical insights based on available data and established methodologies. Results should be validated with domain experts, regulatory consultants, and current market data. The server does not provide legal, medical, financial, or investment advice. Users are responsible for conducting their own diligence and consulting with appropriate professionals.

## Roadmap

- Integration with real patent databases (USPTO, EPO, WIPO APIs)
- Connection to clinical trial databases
- Real-time market pricing and reimbursement data
- ML-powered competitive program prediction
- Advanced deal analytics and precedent matching
- Multi-language support
- Custom report generation

## Changelog

### Version 1.0.0 (Initial Release)
- 6 core tools for pharma AI IP analysis
- Complete TypeScript implementation
- Zod validation schemas
- MCP SDK integration
- Comprehensive documentation
- Production-quality error handling
